Entity Common Stock, Shares Outstanding of Seres Therapeutics, Inc. from 07 Aug 2015 to 31 Oct 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Seres Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 07 Aug 2015 to 31 Oct 2025.
  • Seres Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 31 Oct 2025 was 9,046,519, a 95% decline year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Seres Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 9,046,519 -161,691,550 -95% 31 Oct 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 8,754,570 -142,976,425 -94% 01 Aug 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 174,358,753 +23,349,291 +15% 07 Mar 2025 10-K 13 Mar 2025 2024 FY
Q3 2024 170,738,069 +41,480,870 +32% 08 Nov 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 151,730,995 +23,526,381 +18% 09 Aug 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 151,009,462 +24,933,071 +20% 01 Mar 2024 10-K 05 Mar 2024 2023 FY
Q3 2023 129,257,199 +4,665,458 +3.7% 30 Oct 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 128,204,614 +4,133,059 +3.3% 04 Aug 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 126,076,391 +33,845,963 +37% 03 Mar 2023 10-K 07 Mar 2023 2022 FY
Q3 2022 124,591,741 +32,744,604 +36% 28 Oct 2022 10-Q 02 Nov 2022 2022 Q3
Q2 2022 124,071,555 +32,352,984 +35% 01 Aug 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 92,230,428 +607,759 +0.66% 27 Apr 2022 10-Q 04 May 2022 2022 Q1
Q3 2021 91,847,137 +598,899 +0.66% 03 Nov 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 91,718,571 +15,460,040 +20% 28 Jul 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 91,622,669 +19,023,566 +26% 28 Apr 2021 10-Q 04 May 2021 2021 Q1
Q3 2020 91,248,238 +21,254,286 +30% 03 Nov 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 76,258,531 +6,345,121 +9.1% 22 Jul 2020 10-Q 28 Jul 2020 2020 Q2
Q1 2020 72,599,103 +31,504,271 +77% 01 May 2020 10-Q 07 May 2020 2020 Q1
Q3 2019 69,993,952 +29,138,043 +71% 29 Oct 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 69,913,410 +29,117,747 +71% 31 Jul 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 41,094,832 +446,476 +1.1% 24 Apr 2019 10-Q 02 May 2019 2019 Q1
Q3 2018 40,855,909 +325,770 +0.8% 02 Nov 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 40,795,663 +283,024 +0.7% 26 Jul 2018 10-Q 02 Aug 2018 2018 Q2
Q1 2018 40,648,356 +280,228 +0.69% 02 Mar 2018 10-K 08 Mar 2018 2017 FY
Q3 2017 40,530,139 +174,386 +0.43% 03 Nov 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 40,512,639 +238,136 +0.59% 31 Jul 2017 10-Q 03 Aug 2017 2017 Q2
Q1 2017 40,368,128 +1,181,111 +3% 10 Mar 2017 10-K 16 Mar 2017 2016 FY
Q3 2016 40,355,753 +1,299,986 +3.3% 07 Nov 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 40,274,503 +1,310,863 +3.4% 05 Aug 2016 10-Q 11 Aug 2016 2016 Q2
Q1 2016 39,187,017 07 Mar 2016 10-K 14 Mar 2016 2015 FY
Q3 2015 39,055,767 06 Nov 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 38,963,640 07 Aug 2015 10-Q 10 Aug 2015 2015 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.